McMichael, Andrew J.
Andrew James McMichael Professor of Molecular Medicine, Immunologist
Macmichael, Andrew J
McMichael, A.J.
McMichael, Andrew J., 1943-
VIAF ID: 94956051 (Personal)
Permalink: http://viaf.org/viaf/94956051
Preferred Forms
- 100 0 _ ‡a Andrew James McMichael ‡c Professor of Molecular Medicine, Immunologist
-
- 100 1 _ ‡a MacMichael, Andrew J.
- 100 1 _ ‡a MacMichael, Andrew J.
-
- 200 _ | ‡a McMichael ‡b Andrew J.
-
-
- 100 1 0 ‡a McMichael, Andrew J.
-
- 100 1 _ ‡a McMichael, Andrew J.
-
-
- 100 1 _ ‡a McMichael, Andrew J.
-
4xx's: Alternate Name Forms (17)
Works
Title | Sources |
---|---|
Climate change and human health : risks and responses | |
Complex mixtures and cancer risk | |
Essentials of clinical immunology | |
HLA and MHC : genes, molecules, and function | |
Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays | |
In pursuit of an HIV vaccine: an interview with Andrew McMichael | |
Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection | |
Increased sequence diversity coverage improves detection of HIV-specific T cell responses | |
Influenza vaccines: mTOR inhibition surprisingly leads to protection. | |
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication | |
Innate immune responses in acute HIV-1 infection: protective or pathogenic? | |
Inquiry-based lessons in world history : global expansion to the post-9/11 world. | |
Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide | |
Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort | |
Ita Askonas and her influence in the field of antigen presentation | |
Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection | |
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection | |
Legacy of the influenza pandemic 1918: The host T cell response | |
Lessons learned from HIV-1 vaccine trials: new priorities and directions | |
Leucocyte typing III white cell differentiation antigens | |
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease | |
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection | |
Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. | |
Lymphocytes : a practical approach | |
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza | |
Magnitude of alloresponses to MHC class I/II expressing human cardiac myocytes is limited by their intrinsic ability to process and present antigenic peptides. | |
Mature CD8(+) T lymphocyte response to viral infection during fetal life | |
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals | |
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants | |
Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets | |
Monoclonal antibodies in clinical medicine, 1982 (a.e.) | |
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity | |
Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara | |
Multilayered defense in HLA-B51-associated HIV viral control | |
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study | |
Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling | |
A New look at tumour immunology | |
New templates for HIV-1 antibody-based vaccine design | |
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection | |
Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge | |
A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells | |
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans | |
Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4+T cells in peripheral blood mononuclear cells | |
Options for the control of influenza II : proceedings of the International Conference on Options for the Control of Influenza, Courchevel, 27 September-2 October 1992 | |
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding | |
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression | |
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers | |
Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96. | |
Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection | |
Planetary overload : global environmental change and the health of the human species | |
Polyfunctional T cell responses are a hallmark of HIV-2 infection | |
Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation | |
Preferential detection of HIV subtype C' over subtype A in cervical cells from a dually infected woman | |
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques | |
Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo | |
Prospects for an AIDS vaccine. | |
Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges | |
Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors | |
Quantitating T cell cross-reactivity for unrelated peptide antigens | |
Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners | |
Rational development of high-affinity T-cell receptor-like antibodies | |
Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression | |
Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. | |
Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection | |
Reflecting on a quarter century of HIV research | |
Regulation of immune gene expression, c1986: | |
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection | |
Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable | |
Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E | |
Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus | |
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection | |
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy | |
Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes | |
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape | |
Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes | |
ST111 Immune selection and vpu variability in a unique narrow source HIV-Positive village cohort | |
Strategies for an HIV cure: progress and challenges | |
Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection | |
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms | |
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. | |
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity | |
T cell cross-reactivity and conformational changes during TCR engagement | |
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? | |
T cell responses to whole SARS coronavirus in humans | |
T cell selection during the evolution of CD8+ T cell memory in vivo | |
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection |